Raymond James analyst Melissa Fairbanks downgrades ON Semiconductor (NASDAQ:ON) from Outperform to Market Perform.
Lumos Pharma Q3 EPS $(0.90) Beats $(1.07) Estimate
Lumos Pharma (NASDAQ:LUMO) reported quarterly losses of $(0.90) per share which beat the analyst consensus estimate of $(1.07) by 15.89 percent. This is a 528.57 percent decrease over earnings of $0.21 per share from the
